Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “SION”

1,496 pharma patents match "SION" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,496
Index total 30,257
Page 40 / 63

Quick answer

This filtered view shows 1,496 pharmaceutical patents matching "SION" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,496 results for “SION” · 30,257 patents in full index Clear search

  1. US 9045550

    Peptides and compositions for prevention of cell adhesion and methods of using same

    Tel Hashomer Medical Research, Infrastructure and Services Ltd, the Technology Transfer Company of Chaim · Granted Jun 2, 2015 · Expires May 28, 2035

    granted

  2. US 9044454

    Regulation of microvasculature occlusion

    Northwestern University · Granted Jun 2, 2015 · Expires May 28, 2035

    granted

  3. US 9034588

    Monoclonal antibody therapy for pancreas cancer

    PRECISION BIOLOGICS, INC. · Granted May 19, 2015 · Expires May 14, 2035

    granted

  4. US 9028809

    Compositions, methods and uses for expression of enterobacterium-associated peptides

    Takeda Vaccines, Inc. · Granted May 12, 2015 · Expires May 7, 2035

    granted

  5. US 9029525

    Compositions and methods for inhibiting expression of GSK-3 genes

    Alnylam Pharmaceuticals, Inc. · Granted May 12, 2015 · Expires May 7, 2035

    granted

  6. US 9029318

    Peptides and compositions for prevention of cell adhesion and methods of using same

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted May 12, 2015 · Expires May 7, 2035

    granted

  7. US 9029338

    Lipid formulated compositions and methods for inhibiting expression of a gene from the ebola virus

    Alnylam Pharmaceuticals, Inc. · Granted May 12, 2015 · Expires May 7, 2035

    granted

  8. US 9029521

    EML4-ALK fusion gene

    CUREGENE K.K. · Granted May 12, 2015 · Expires May 7, 2035

    granted

  9. IL 172160

    Method for non-invasive quantification of perfusion in a tissue

    BRACCO SUISSE SA [CH] · Granted Apr 30, 2015 · Expires Apr 25, 2035

    granted

  10. US 9018236

    Cyclodextrin-based microemulsions, and dermatological uses thereof

    Precision Dermatology, Inc. · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted

  11. US 9011888

    Organic-inorganic composite particles, process for producing the same, dispersion containing the particles, and cosmetic containing the particles

    JGC Catalysts and Chemicals Ltd. · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  12. US 9012624

    Compositions and methods for inhibiting expression of a gene from the JC virus

    Alnylam Pharmaceuticals, Inc. · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  13. US 9012134

    CD127 expression inversely correlates with FoxP3 and suppressive function of CD4+ Tregs

    The Regents of the University of California · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  14. US 9006197

    Compositions and methods for inhibiting expression of Eg5 and VEGF genes

    Alnylam Pharmaceuticals, Inc. · Granted Apr 14, 2015 · Expires Apr 9, 2035

    granted

  15. US 9000143

    Compositions and methods for inhibiting expression of IKK-B gene

    Alnylam Pharmaceuticals, Inc. · Granted Apr 7, 2015 · Expires Apr 2, 2035

    granted

  16. US 9000089

    Polyurea systems, processes for preparing the same and use thereof for postoperative adhesion barriers

    Medical Adhesive Revolution GmbH · Granted Apr 7, 2015 · Expires Apr 2, 2035

    granted

  17. US 8987426

    Immunotoxin fusion proteins and means for expression thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted

  18. US 8986695

    Enhanced staphylolytic activity of the Staphylococcus aureus bacteriophage vB—SauS-philPLA88 virion-associated peptidoglycan hydrolase HydH5: fusions, deletions and synergy with LysH5

    The United States of America, as represented by the Secretary of Agriculture · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted

  19. US 8989847

    Method of measuring propulsion in lymphatic structures

    The Board of Regents of the University of Texas System · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted

  20. US 8987227

    Hepatitis C dsRNA effector molecules, expression constructs, compositions, and methods of use

    Alnylam Pharmaceuticals, Inc. · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted

  21. US 8986688

    WAP domain fusion polypeptides and methods of use thereof

    Inhibrx, Inc. · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted

  22. US 8980266

    Serpin fusion polypeptides and methods of use thereof

    Inhibrx, Inc. · Granted Mar 17, 2015 · Expires Mar 12, 2035

    granted

  23. US 8981057

    B-cell stimulating fusion proteins of an antigen with BAFF or APRIL

    ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM · Granted Mar 17, 2015 · Expires Mar 12, 2035

    granted

  24. US 8974801

    Long term sustained release pharmaceutical composition containing aqueous suspension of bisphosphonate

    Amphastar Pharmaceuticals, Inc. · Granted Mar 10, 2015 · Expires Mar 5, 2035

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.